We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
StoneCo
STNE
$2.53B
| $76K | ﹤0.01% |
+906
| New | +$60.7K |
|
652
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $76K | ﹤0.01% |
1,120
-5
| -0.4% | -$329 |
|
653
Ares Capital
ARCC
$14.3B
| $75K | ﹤0.01% |
4,440
+2,940
| +196% | +$45.6K |
|
654
Ferrari
RACE
$71.5B
| $75K | ﹤0.01% |
+327
| New | +$66.7K |
|
655
DuPont de Nemours
DD
$19.2B
| $74K | ﹤0.01% |
829
-258
| -24% | -$20.3K |
|
656
APA Corp
APA
$14.4B
| $73K | ﹤0.01% |
5,144
-6
| -0.1% | -$70 |
|
657
Southern Company
SO
$105B
| $73K | ﹤0.01% |
+1,188
| New | +$71.4K |
|
|
BEAT
658
DELISTED
BioTelemetry, Inc.
BEAT
| $72K | ﹤0.01% |
999
-503
| -33% | -$26.3K |
|
659
BlackLine
BL
$1.69B
| $67K | ﹤0.01% |
502
+2
| +0.4% | +$223 |
|
660
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.3B
| $66K | ﹤0.01% |
1,003
+403
| +67% | +$20.1K |
|
661
Hecla Mining
HL
$11.7B
| $65K | ﹤0.01% |
10,031
+31
| +0.3% | +$165 |
|
662
Dynatrace
DT
$14.6B
| $62K | ﹤0.01% |
1,433
-8,964
| -86% | -$356K |
|
663
Northrop Grumman
NOC
$81.9B
| $62K | ﹤0.01% |
203
+168
| +480% | +$51.4K |
|
664
ASML
ASML
$671B
| $61K | ﹤0.01% |
125
-649
| -84% | -$273K |
|
|
AYX
665
DELISTED
Alteryx Inc
AYX
| $61K | ﹤0.01% |
501
-38,792
| -99% | -$4.89M |
|
666
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $60K | ﹤0.01% |
+2,139
| New | +$58.1K |
|
667
American Airlines Group
AAL
$10B
| $59K | ﹤0.01% |
3,741
-888
| -19% | -$12.3K |
|
|
AEGN
668
DELISTED
Aegion Corp
AEGN
| $59K | ﹤0.01% |
3,107
+7
| +0.2% | +$117 |
|
669
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $58K | ﹤0.01% |
+1,212
| New | +$54K |
|
670
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $58K | ﹤0.01% |
1,754
+14
| +0.8% | +$463 |
|
671
Box
BOX
$4.67B
| $56K | ﹤0.01% |
3,102
-18,387
| -86% | -$320K |
|
672
Cyclerion Therapeutics
CYCN
$16.5M
| $55K | ﹤0.01% |
+899
| New | +$61.3K |
|
673
Zimmer Biomet
ZBH
$18.6B
| $55K | ﹤0.01% |
368
-1,343
| -78% | -$190K |
|
674
VanEck Africa Index ETF
AFK
$105M
| $54K | ﹤0.01% |
2,650
+10
| +0.4% | +$193 |
|
675
QuidelOrtho
QDEL
$931M
| $54K | ﹤0.01% |
+301
| New | +$66.9K |
|
Similar funds
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.